| Identification | Back Directory | [Name]
GINSENOSIDEF1 | [CAS]
53963-43-2 | [Synonyms]
Ginsenoside F1
GINSENOSIDE F1(P)
20(S)-Ginsenoside F1
Panaxoside Aprogenin
Ginsenoside F1 (20(S)-Ginsenoside F1)
Ginsenoside F1, 98%, from Panax ginseng C. A. Mey.
(20S)-20-(β-D-Glucopyranosyloxy)dammar-24-ene-3β,6α,12β-triol
3β,6α,12β-Trihydroxy-5α-dammar-24-en-20-yl β-D-glucopyranoside
(3b,6a,12b)-3,6,12-Trihydroxydammar-24-ene-20-yl beta-D-glucopyranoside
β-D-Glucopyranoside, (3β,6α,12β)-3,6,12-trihydroxydammar-24-en-20-yl (9CI)
20(S)-Ginsenoside F1(3b,6a,12b)-3,6,12-Trihydroxydammar-24-ene-20-yl beta-D-glucopyranoside | [Molecular Formula]
C36H62O9 | [MDL Number]
MFCD06410947 | [MOL File]
53963-43-2.mol | [Molecular Weight]
638.87 |
| Chemical Properties | Back Directory | [Melting point ]
>165°C (dec.) | [Boiling point ]
751.7±60.0 °C(Predicted) | [density ]
1.23±0.1 g/cm3(Predicted) | [storage temp. ]
Sealed in dry,Room Temperature | [solubility ]
DMSO (Slightly), Methanol (Slightly ) | [form ]
powder | [pka]
12.94±0.70(Predicted) | [color ]
Pale Yellow |
| Hazard Information | Back Directory | [Uses]
Ginsenoside F1 is a bioactive metabolite of the ginsenoside component of Panax ginseng with the ability to inhibit human cytochrome P450 enzymes. This has application in anti-cancer therapeutics as well as protective liver effects. | [Definition]
ChEBI: A ginsenoside found in Panax species that is dammarane which is substituted by hydroxy groups at the 3beta, 6alpha, 12beta and 20 pro-S positions, in which the hy
roxy group at position 20 has been converted to the corresponding beta-D-glucopyranoside, and in which a double bond has been introduced at the 24-25 position. |
|
|